Insider sale
DYNE THERAPEUTICS, INC.
$258.2K
12.70K shares
What this filing means
ATLAS VENTURE FUND XI, L.P. plans to sell 12.70K shares of DYNE THERAPEUTICS, INC. valued at approximately $258.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001628280-26-045611
10% Owner
Since Sep 2020
12.70K
Shares to sell
$258.2K
Approx. market value
12.70K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
7/31/2020
12.70KTotal acquired12.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2020 | Private Placement Cash | 12.70K | — |
| Total | 12.70K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
12.70K
Market value
$258.2K
6/25/2026
Total
Units
12.70K
Value
$258.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/25/2026 | 12.70K | $258.2K | Nasdaq | Planned |
| Total | 12.70K | $258.2K | ||